Aria CV
Developer of an implantable cardiovascular device designed to treat pulmonary hypertension. The company's devices reduce the workload on the heart and have the potential to enhance both the survival a...
Valuation
$68.6M
Latest known
Share Price
N/A
Total Raised
$50.2M
Last Round
N/A